BT3 DCF Valuation - Lineage Cell Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

L

Watchlist Manager

Watchlist

Price: 1.35 EUR Market Closed

Market Cap: €395.1m

L	Lineage Cell Therapeutics Inc XBER:BT3	US
C	Carnival PLC XBER:POH1	UK
	Bilibili Inc NASDAQ:BILI	CN
U	United Therapeutics Corp XBER:UTH	US
	Volkswagen AG XETRA:VOW	DE
N	Note AB (publ) LSE:0GSS	SE
T	Target Corp XBER:DYH	US
M	MillerKnoll Inc NASDAQ:MLKN	US
E	East Japan Railway Co XBER:EJR	JP
S	Societe Generale SA DUS:SGE	FR
	Ally Financial Inc NYSE:ALLY	US
P	Petroleo Brasileiro SA Petrobras XBER:PJX	BR

BT3's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

Continue BT3 Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

F • EUR

BT3

TASE • ILS

LCTX

AMEX • USD

LCTX

Join 348,100+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.